These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 22306349

  • 1. Clinical value of circulating endothelial cell detection in oncology.
    Kraan J, Sleijfer S, Foekens JA, Gratama JW.
    Drug Discov Today; 2012 Jul; 17(13-14):710-7. PubMed ID: 22306349
    [Abstract] [Full Text] [Related]

  • 2. Circulating endothelial cells as biomarkers in clinical oncology.
    Mancuso P, Bertolini F.
    Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
    Bertolini F.
    Breast; 2009 Oct; 18 Suppl 3():S48-50. PubMed ID: 19914542
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
    Twardowski PW, Smith-Powell L, Carroll M, VanBalgooy J, Ruel C, Frankel P, Synold TW.
    Cancer Invest; 2008 Feb; 26(1):53-9. PubMed ID: 18181046
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Circulating endothelial cells as biomarkers of prostate cancer.
    Georgiou HD, Namdarian B, Corcoran NM, Costello AJ, Hovens CM.
    Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells.
    Bertolini F.
    Cancer Metastasis Rev; 2008 Mar; 27(1):95-101. PubMed ID: 18066648
    [Abstract] [Full Text] [Related]

  • 11. Circulating tumour cells and circulating endothelial cells as biomarkers in oncology.
    Strijbos MH.
    Acta Clin Belg; 2011 Mar; 66(5):332-6. PubMed ID: 22145267
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
    Goodale D, Phay C, Brown W, Gray-Statchuk L, Furlong P, Lock M, Chin-Yee I, Keeney M, Allan AL.
    Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
    [Abstract] [Full Text] [Related]

  • 13. On the origin of (CD105+) circulating endothelial cells.
    Strijbos MH, Verhoef C, Gratama JW, Sleijfer S.
    Thromb Haemost; 2009 Aug; 102(2):347-51. PubMed ID: 19652886
    [Abstract] [Full Text] [Related]

  • 14. Circulating endothelial cells: a novel marker of endothelial damage.
    Erdbruegger U, Haubitz M, Woywodt A.
    Clin Chim Acta; 2006 Nov; 373(1-2):17-26. PubMed ID: 16836991
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circulating endothelial cells and circulating endothelial progenitors.
    Mancuso P, Calleri A, Bertolini F.
    Recent Results Cancer Res; 2012 Nov; 195():163-70. PubMed ID: 22527503
    [Abstract] [Full Text] [Related]

  • 17. Circulating endothelial cells and their subpopulations: role as predictive biomarkers in antiangiogenic therapy for colorectal cancer.
    Manzoni M, Comolli G, Torchio M, Mazzini G, Danova M.
    Clin Colorectal Cancer; 2015 Mar; 14(1):11-7. PubMed ID: 25591800
    [Abstract] [Full Text] [Related]

  • 18. Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy.
    Mehran R, Nilsson M, Khajavi M, Du Z, Cascone T, Wu HK, Cortes A, Xu L, Zurita A, Schier R, Riedel B, El-Zein R, Heymach JV.
    Cancer Res; 2014 May 15; 74(10):2731-41. PubMed ID: 24626092
    [Abstract] [Full Text] [Related]

  • 19. Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials.
    Devriese LA, Voest EE, Beijnen JH, Schellens JH.
    Cancer Treat Rev; 2011 Dec 15; 37(8):579-89. PubMed ID: 21592671
    [Abstract] [Full Text] [Related]

  • 20. Molecular and cellular biomarkers for angiogenesis in clinical oncology.
    Bertolini F, Mancuso P, Shaked Y, Kerbel RS.
    Drug Discov Today; 2007 Oct 15; 12(19-20):806-12. PubMed ID: 17933680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.